DNA-WT NYSE
Ginkgo Bioworks Holdings, Inc. WT
1W: -4.7%
1M: -27.8%
3M: +17.6%
1Y: +79.7%
$0.27
Last traded 2025-03-10 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$171M
+46.5% ▲
Capital Expenditures
$8M
+87.7% ▲
5Y CAGR: -33.2%
Free Cash Flow
-$179M
+53.2% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$393M
-2.4% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$1.8B | -$2.1B | -$893M | -$547M | -$313M |
| Depreciation & Amort. | $29M | $43M | $72M | $63M | $59M |
| Stock-Based Comp. | $1.6B | $1.9B | $230M | $112M | $82M |
| Change in Working Capital | -$62M | -$37M | $30M | -$90M | -$44M |
| Other Non-Cash Items | -$21M | -$67M | $267M | $143M | $47M |
| Operating Cash Flow | -$254M | -$252M | -$296M | -$320M | -$171M |
| — Investing Activities — | |||||
| Capital Expenditures | -$57M | -$52M | -$41M | -$63M | -$8M |
| Acquisitions (Net) | -$12M | $27M | -$39M | -$5M | $0 |
| Investment Purchases | -$5M | -$4M | $0 | $0 | -$419M |
| Investment Sales | $0 | $0 | $0 | $5M | $185M |
| Other Investing | $304K | -$38M | -$1M | $1M | $624K |
| Investing Cash Flow | -$73M | -$67M | -$81M | -$62M | -$240M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$1M | -$1M | -$1M | -$897K | -$354K |
| Stock Repurchased | -$25M | $0 | -$23K | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $1.6B | -$3M | -$1M | -$922K | $0 |
| Financing Cash Flow | $1.5B | $95M | -$3M | -$2M | $18M |
| Net Change in Cash | $1.2B | -$223M | -$380M | -$384M | -$393M |
| Cash End of Period | $1.6B | $1.4B | $990M | $606M | $174M |
| Free Cash Flow | -$310M | -$304M | -$336M | -$382M | -$179M |